title: Physicians' perception of generic and electronic prescribing: A descriptive study from Jordan.
abstract: OBJECTIVE
  The aim of this study was to investigate Jordanian physicians' perception and attitudes toward generic medicines and generic substitution. It also aimed to examine factors that affect physicians' pattern of prescribing, and to evaluate their opinion regarding future introduction of Electronic Prescribing (EP) in Jordan.
  
  
  METHODS
  A cross-sectional descriptive study involving Jordanian physicians working in both public and private sectors was undertaken, using a self-administrated anonymous questionnaire. Frequency tables, cross-tabulation and chi square tests were used for data analysis. The response rate was 75.2% (n = 376/500).
  
  
  RESULTS
  Cost was claimed to be an important factor in the prescribing decision for 69.1% of the Jordanian physicians. The majority of physicians (77.4%) claimed that they often prescribe generic medicines. Jordanian physicians predominantly welcomed the implementation of an EP and International Nonproprietary Name (INN) prescribing systems with 92%, and 80.1% respectively. More than two thirds of the physicians (69.4%) accepted generic substitution by pharmacists, with a significant association with their employment sector; physicians who work in the private sector tended to oppose generic substitution compared with physicians who work in the public sector. Physicians mostly (72.1%) opposed that generic substitution should only be allowed upon patient request.
  
  
  CONCLUSIONS
  Jordanian physicians have a positive attitude towards generic medications and high willingness and acceptance of strategies that encourage generic utilisation such as EP, INN prescribing and generic substitution. All these strategies would help reduce the high expenditure on medicines in Jordan. These findings would provide baseline data to policy makers to develop a robust generic policy to achieve greater clinical effectiveness and economic efficiency from medicines prescribing.
authors.affiliation: Faculty of Pharmacy, Isra University, Amman, Jordan.
authors.forename: Faris
authors.initials: F
authors.lastname: El-Dahiyat
authors.affiliation: Pharmacy Department, Kingston University, Penrhyn Road, Kingston upon Thames KT1 2EE, UK.
authors.forename: Reem
authors.initials: R
authors.lastname: Kayyali
authors.affiliation: Mathematics Department, Kingston University, Penrhyn Road, Kingston upon Thames KT1 2EE, UK.
authors.forename: Penelope
authors.initials: P
authors.lastname: Bidgood
keywords: Electronic Prescribing; Generic medicines; Generic substitution; INN prescribing; Physicians; Policy
references.citation: Br J Clin Pharmacol. 2008 Feb;65(2):230-7
references.pmid: 17662088
references.citation: Health Aff (Millwood). 2009 Mar-Apr;28(2):546-56
references.pmid: 19276015
references.citation: J Am Pharm Assoc (2003). 2010 Mar-Apr 1;50(2):e20-31, quiz e32-4
references.pmid: 20199946
references.citation: Soc Sci Med. 1988;27(12):1381-6
references.pmid: 3238456
references.citation: Health Policy. 2010 May;95(2-3):229-35
references.pmid: 20044165
references.citation: Am J Health Syst Pharm. 2011 Jan 15;68(2):158-63
references.pmid: 21200064
references.citation: J Clin Pharmacol. 2003 Jul;43(7):768-83
references.pmid: 12856392
references.citation: Res Social Adm Pharm. 2012 Nov-Dec;8(6):523-32
references.pmid: 22264963
references.citation: Arch Intern Med. 2003 Oct 13;163(18):2213-8
references.pmid: 14557219
references.citation: Arch Intern Med. 2003 Jul 28;163(14):1673-81
references.pmid: 12885682
references.citation: Health Policy. 2004 Oct;70(1):23-32
references.pmid: 15312707
references.citation: J Health Econ. 2000 Mar;19(2):159-95
references.pmid: 10947575
references.citation: CMAJ. 2003 Sep 2;169(5):405-12
references.pmid: 12952801
references.citation: J Clin Pharm Ther. 2009 Oct;34(5):547-54
references.pmid: 19744010
references.citation: Pan Afr Med J. 2011;9:13
references.pmid: 22145057
references.citation: Croat Med J. 2002 Aug;43(4):462-9
references.pmid: 12187525
references.citation: Curr Med Res Opin. 2007 Jan;23 (1):105-16
references.pmid: 17257472
references.citation: JAMA. 2000 Jan 19;283(3):373-80
references.pmid: 10647801
references.citation: Pharmacoeconomics. 2003;21(2):89-103
references.pmid: 12515571
references.citation: BMC Health Serv Res. 2009 Aug 20;9:150
references.pmid: 19695079
references.citation: Soc Sci Med. 1982;16(23):2017-23
references.pmid: 7157034
references.citation: Br J Gen Pract. 1997 Jan;47(414):13-8
references.pmid: 9115786
references.citation: Scand J Prim Health Care. 2007 Dec;25(4):208-13
references.pmid: 18041657
references.citation: J Pharm Pharm Sci. 2003 Jan-Apr;6(1):84-94
references.pmid: 12753731
references.citation: Br J Clin Pharmacol. 2011 Nov;72(5):727-30
references.pmid: 21486316
references.citation: Soc Sci Med. 2009 Dec;69(11):1643-50
references.pmid: 19815322
references.citation: Health Policy. 2000 Apr;51(3):149-62
references.pmid: 10720685
references.citation: Health Policy Plan. 1996 Jun;11(2):198-205
references.pmid: 10158460
references.citation: Health Policy. 2007 Aug;82(3):366-74
references.pmid: 17141355
references.citation: Soc Sci Med. 2006 Jul;63(1):225-38
references.pmid: 16459005
references.citation: JAMA. 2003 Aug 20;290(7):953-8
references.pmid: 12928475
references.citation: Arch Intern Med. 2000 Oct 9;160(18):2799-803
references.pmid: 11025790